Pituitary Diseases  >>  Signifor LAR (pasireotide long acting release)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Signifor LAR (pasireotide long acting release) / Recordati
ACCESS, NCT01995734: An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly

Approved for marketing
N/A
US
Pasireotide long acting release formulation, SOM230 LAR
Novartis Pharmaceuticals
Acromegaly
 
 

Download Options